Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Knowledge Synthesis Grant

McMaster University

$100,000.00

The efficacy and safety of medical cannabis for chronic non cancer pain: a systematic review and meta-analysis of randomized controlled trials.

FY 2015-16

Summary
Background Chronic non-cancer pain (CNCP) is a common and debilitating problem that affects one third of Canadians and is associated with enormous socioeconomic loss. There is an urgent need for new treatment options, as existing options provide limited relief and/or are associated with important side effects. Medical cannabis is a potential therapeutic option for chronic pain relief; however, intense controversy surrounds this area and many healthcare providers are wary about prescribing cannabis for chronic pain. A high quality synthesis of all available evidence is needed to ensure that policy and clinical decisions regarding use of medical cannabis for CNCP are evidence-based. Objective To systematically review the literature in order to evaluate the safety and effectiveness of medical cannabis for CNCP. Methods Studies eligible for our systematic review will enroll adults with CNCP and randomize them to receive cannabis or a control arm of placebo or care-as-usual. In collaboration with a medical librarian, we will search MEDLINE, EMBASE, AMED, Cochrane CENTRAL, CINAHL, and PsycINFO for eligible studies. We will review bibliographies of included articles, and contact industry representatives to identify additional potentially eligible articles. We will use current best practices to assess risk of bias, and extract study data, facilitated by software designed to optimize the conduct of systematic reviews (DistillerSR). We will collect data for all patient-important outcomes. When trialists report outcomes for a common domain (e.g. pain) using different continuous outcome measures, we will convert all effects to a common outcome measure to facilitate pooling in natural units and optimize interpretability by presenting both relative and absolute effects. We will use random effects models for all meta-analyses, and conduct sub-group analyses to explore heterogeneity among pooled effect estimates. We will evaluate the quality of evidence for all outcomes using the GRADE rating system. Feasibility Our multidisciplinary study team has extensive experience with systematic reviews for management of CNCP, and includes methodologists, clinical experts, a biostatistician, and a medical librarian. We have designed a comprehensive search strategy, study screening forms, and detailed data extraction forms for our proposed review. Our principal applicant, Dr. Ware, and two co-applicants, Drs. Lynch and Campbell, are accomplished researchers in the area of cannabinoids and pain management. We have partnered with the Canadian Pain Coalition, the Canadian Pain Society, the Canadian Consortium for the Investigation of Cannabinoids, and the National Pain Centre to facilitate widespread dissemination of our results. Significance The most recent systematic review concluded that medical cannabis is effective for CNCP1; however, this review has important limitations, including combining both cancer and non-cancer chronic pain trials, pooling of only 10 of 28 trials, inadequate assessment of both risk of bias and the overall quality of evidence, and concluding effectiveness on the basis of a non-significant effect and a clinically trivial effect. Our systematic review will address these limitations and summarize the current best evidence regarding the safety and efficacy of cannabis for CNCP. Our findings will be highly relevant to clinicians managing patients with CNCP, patients living with CNCP, and policy-makers.
Program
Knowledge Synthesis Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
346792
Name
Busse Jason W
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Knowledge Synthesis Grant
Projecttitle
The efficacy and safety of medical cannabis for chronic non cancer pain: a systematic review and meta-analysis of randomized controlled trials.
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Knowledge Synthesis Grant
Keyworddelim
Chronic Non-Cancer Pain; Medical Cannabis; Systematic Review And Meta-Analysis
Abstract
<html> <body> <p> <strong>Background</strong> </p> <p>Chronic non-cancer pain (CNCP) is a common and debilitating problem that affects one third of Canadians and is associated with enormous socioeconomic loss. There is an urgent need for new treatment options, as existing options provide limited relief and/or are associated with important side effects. Medical cannabis is a potential therapeutic option for chronic pain relief; however, intense controversy surrounds this area and many healthcare providers are wary about prescribing cannabis for chronic pain. A high quality synthesis of all available evidence is needed to ensure that policy and clinical decisions regarding use of medical cannabis for CNCP are evidence-based.</p> <p> <strong>Objective</strong> </p> <p>To systematically review the literature in order to evaluate the safety and effectiveness of medical cannabis for CNCP.</p> <p> <strong>Methods</strong> <br> </p> <p>Studies eligible for our systematic review will enroll adults with CNCP and randomize them to receive cannabis or a control arm of placebo or care-as-usual. In collaboration with a medical librarian, we will search MEDLINE, EMBASE, AMED, Cochrane CENTRAL, CINAHL, and PsycINFO for eligible studies. We will review bibliographies of included articles, and contact industry representatives to identify additional potentially eligible articles.<br> We will use current best practices to assess risk of bias, and extract study data, facilitated by software designed to optimize the conduct of systematic reviews (DistillerSR). We will collect data for all patient-important outcomes. When trialists report outcomes for a common domain (e.g. pain) using different continuous outcome measures, we will convert all effects to a common outcome measure to facilitate pooling in natural units and optimize interpretability by presenting both relative and absolute effects. We will use random effects models for all meta-analyses, and conduct sub-group analyses to explore heterogeneity among pooled effect estimates. We will evaluate the quality of evidence for all outcomes using the GRADE rating system.</p> <p> <strong>Feasibility</strong> </p> <p>Our multidisciplinary study team has extensive experience with systematic reviews for management of CNCP, and includes methodologists, clinical experts, a biostatistician, and a medical librarian. We have designed a comprehensive search strategy, study screening forms, and detailed data extraction forms for our proposed review. Our principal applicant, Dr. Ware, and two co-applicants, Drs. Lynch and Campbell, are accomplished researchers in the area of cannabinoids and pain management. We have partnered with the Canadian Pain Coalition, the Canadian Pain Society, the Canadian Consortium for the Investigation of Cannabinoids, and the National Pain Centre to facilitate widespread dissemination of our results.<br> </p> <p> <strong>Significance</strong> <br> </p> <p>The most recent systematic review concluded that medical cannabis is effective for CNCP<sup>1</sup>; however, this review has important limitations, including combining both cancer and non-cancer chronic pain trials, pooling of only 10 of 28 trials, inadequate assessment of both risk of bias and the overall quality of evidence, and concluding effectiveness on the basis of a non-significant effect and a clinically trivial effect. Our systematic review will address these limitations and summarize the current best evidence regarding the safety and efficacy of cannabis for CNCP. Our findings will be highly relevant to clinicians managing patients with CNCP, patients living with CNCP, and policy-makers.</p> </body> </html>
Competitiondate
201601
Approvedterm2
1 yr 0 mth
Pinamesdelim
Busse, Jason W; Ware, Mark A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~